| US 7,488,479 B2 | ||
| Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer | ||
| Mary Faris, Los Angeles, Calif. (US); Pia M. Challita-Eid, Encino, Calif. (US); Rene S. Hubert, Los Angeles, Calif. (US); Daniel E. H. Afar, Brisbane, Calif. (US); Arthur B. Raitano, Los Angeles, Calif. (US); Wangmao Ge, Culver City, Calif. (US); Robert Kendall Morrison, Santa Monica, Calif. (US); Karen Jane Meyrick Morrison, Santa Monica, Calif. (US); and Aya Jakobovits, Beverly Hills, Calif. (US) | ||
| Assigned to Agensys, Inc., Santa Monica, Calif. (US) | ||
| Filed on Mar. 13, 2002, as Appl. No. 10/99,460. | ||
| Application 10/099460 is a continuation in part of application No. 09/809638, filed on Mar. 14, 2001, granted, now 7,271,240. | ||
| Prior Publication US 2003/0219444 A1, Nov. 27, 2003 | ||
| Int. Cl. A61K 39/00 (2006.01) | ||
| U.S. Cl. 424—185.1 | 3 Claims |
| 1. A method of generating a mammalian immune response directed to a protein, comprising:
exposing cells of the mammal's immune system to an immunogenic portion of the protein, wherein the protein comprises the amino
acid sequence of SEQ ID NO: 3.
|